Biosimilars News News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biosimilars news. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biosimilars News Today - Breaking & Trending Today

Regeneron Sues Samsung Bioepis For Proposed Biosimilar Of EYLEA In West Virginia District Court - Life Sciences, Biotechnology & Nanotechnology

Regeneron Pharmaceuticals, Inc. ("Regeneron") filed a Complaint on November 22 against Samsung Bioepis Co., Ltd. ("Bioepis") in the U.S. District Court for the Northern District of West Virginia. ....

West Virginia , United States , Us District Court , Bioepis Co Ltd , Regeneron Pharmaceuticals Inc , Regeneron Pharmaceuticals , Northern District , Commercial Marketing , Big Molecule Watch , Biosimilars News , Samsung Bioepis , Life Sciences , Life Sciences , Iotechnology Amp Nanotechnology , Intellectual Property ,

Celltrion's Anticancer Biosimilar Debuts In Japan - Life Sciences, Biotechnology & Nanotechnology

According to news reports, Celltrion recently launched VEGZELMA (bevacizumab) in Japan. In September 2022, the drug received sales approval from the Japanese Ministry of Health, Labor and Welfare. ....

New York , United States , Kurnit Klein Selz , Lorna Doone , Foley Lardner , Sheppard Mullin Richter Hampton , Foley Hoag , Life Sciences , Drug Administration , Health Products Compliance Guidance On , Federal Trade Commission , Health Products Compliance Guidance , Western District , Mondelez Global , False Claims Act , Drug Omnibus Reform Act , Biosimilars News , Life Sciences , Iotechnology Amp Nanotechnology ,

Year In Review: Top Legal Developments Of 2022 - Patent

As we ring in the new year, we look back at the top legal developments of 2022 that could influence the market for biologics and biosimilars. ....

United States , Regeneron Praluent , Amgen Repatha , Supreme Court Grants Cert To Address Enablement , Regeneron Pharmaceuticals Inc , Us Court , Us District Court , Us Supreme Court , Amgen Inc , Abbvie Inc , Federal Circuit , Court Grants Cert , Address Enablement , Regeneron Pharmaceuticals , Biosimilar Related , Seventh Circuit Affirms Dismissal , Seventh Circuit , Northern District , Biosimilars News , Federal Circuit , Antitrust Competition Law , U Competition , Intellectual Property ,

Similis Bio And Blau Farmaceutica Enter Into Development And License Agreement For Biosimilars - Life Sciences, Biotechnology & Nanotechnology

On October 25, 2022, JSR Life Sciences and Blau Farmaceutica announced that Similis Bio, JSR Life Sciences's business unit focused on biosimilar development, has signed its first development and license agreement. ....

Simils Bio , Blau Farmaceutica , Similis Bio , Life Sciences , Biosimilars News , Blau Farmaceutica , Simils Bio , Life Sciences , Iotechnology Amp Nanotechnology ,

Request For Comments On USPTO Initiatives To Promote Generic Drug And Biosimilar Competition - Patent

The U.S. Patent and Trademark Office (USPTO) recently published a request for comments addressing a variety of topics related to generic drug and biosimilar competition. ....

United States , Trademark Office , Health Human Services , President Biden , American Economy , Human Services , Patents End To Search , Patent Act , Biosimilars News , Us Patent And Trademark Office , Intellectual Property ,